These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 22498766)

  • 1. Regulatory T cells in atherogenesis.
    Sasaki N; Yamashita T; Takeda M; Hirata K
    J Atheroscler Thromb; 2012; 19(6):503-15. PubMed ID: 22498766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulatory T cells and tolerogenic dendritic cells as critical immune modulators in atherogenesis.
    Sasaki N; Yamashita T; Kasahara K; Takeda M; Hirata K
    Curr Pharm Des; 2015; 21(9):1107-17. PubMed ID: 25312730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory T cells in atherosclerosis and strategies to induce the endogenous atheroprotective immune response.
    Chistiakov DA; Sobenin IA; Orekhov AN
    Immunol Lett; 2013 Mar; 151(1-2):10-22. PubMed ID: 23411158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treating atherosclerosis with regulatory T cells.
    Foks AC; Lichtman AH; Kuiper J
    Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):280-7. PubMed ID: 25414253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory T Cell Immunity in Atherosclerosis.
    Amin HZ; Sasaki N; Hirata KI
    Acta Med Indones; 2017 Jan; 49(1):63-68. PubMed ID: 28450656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory T cells in atherosclerosis: critical immune regulatory function and therapeutic potential.
    Spitz C; Winkels H; Bürger C; Weber C; Lutgens E; Hansson GK; Gerdes N
    Cell Mol Life Sci; 2016 Mar; 73(5):901-22. PubMed ID: 26518635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokine network and T cell immunity in atherosclerosis.
    Ait-Oufella H; Taleb S; Mallat Z; Tedgui A
    Semin Immunopathol; 2009 Jun; 31(1):23-33. PubMed ID: 19340429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dendritic cells in atherogenesis: possible novel targets for prevention of atherosclerosis.
    Takeda M; Yamashita T; Sasaki N; Hirata K
    J Atheroscler Thromb; 2012; 19(11):953-61. PubMed ID: 22878702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of CD4+/CD25+ regulatory T cells on atherogenesis in patients with end-stage kidney disease.
    Meier P; Meier R; Blanc E
    Expert Rev Cardiovasc Ther; 2008 Aug; 6(7):987-97. PubMed ID: 18666849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranasal immunization with heat shock protein 60 induces CD4(+) CD25(+) GARP(+) and type 1 regulatory T cells and inhibits early atherosclerosis.
    Zhong Y; Tang H; Wang X; Zeng Q; Liu Y; Zhao XI; Yu K; Shi H; Zhu R; Mao X
    Clin Exp Immunol; 2016 Mar; 183(3):452-68. PubMed ID: 26452441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral FTY720 administration induces immune tolerance and inhibits early development of atherosclerosis in apolipoprotein E-deficient mice.
    Huang K; Li SQ; Wang WJ; Liu LS; Jiang YG; Feng PN; Wang YQ; Wang SM
    Int J Immunopathol Pharmacol; 2012; 25(2):397-406. PubMed ID: 22697071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-inflammatory and immune-modulatory therapies for preventing atherosclerotic cardiovascular disease.
    Yamashita T; Sasaki N; Kasahara K; Hirata K
    J Cardiol; 2015 Jul; 66(1):1-8. PubMed ID: 25744783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory T-cell immunity and its relevance to atherosclerosis.
    Taleb S; Tedgui A; Mallat Z
    J Intern Med; 2008 May; 263(5):489-99. PubMed ID: 18410592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of disease: the evolving role of regulatory T cells in atherosclerosis.
    George J
    Nat Clin Pract Cardiovasc Med; 2008 Sep; 5(9):531-40. PubMed ID: 18607396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulatory T cells as a new therapeutic target for atherosclerosis.
    Ou HX; Guo BB; Liu Q; Li YK; Yang Z; Feng WJ; Mo ZC
    Acta Pharmacol Sin; 2018 Aug; 39(8):1249-1258. PubMed ID: 29323337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory T Cell-Enhancing Therapies to Treat Atherosclerosis.
    Ait-Oufella H; Lavillegrand JR; Tedgui A
    Cells; 2021 Mar; 10(4):. PubMed ID: 33805071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory T cells: a review.
    Dasgupta A; Saxena R
    Natl Med J India; 2012; 25(6):341-51. PubMed ID: 23998865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral anti-CD3 antibody treatment induces regulatory T cells and inhibits the development of atherosclerosis in mice.
    Sasaki N; Yamashita T; Takeda M; Shinohara M; Nakajima K; Tawa H; Usui T; Hirata K
    Circulation; 2009 Nov; 120(20):1996-2005. PubMed ID: 19884470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity of Tregs and the complexity in the IL-12 cytokine family signaling in driving T-cell immune responses in atherosclerotic vessels.
    Chistiakov DA; Bobryshev YV; Orekhov AN
    Mol Immunol; 2015 May; 65(1):133-8. PubMed ID: 25659084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adaptive T cell immune responses and atherogenesis.
    Taleb S; Tedgui A; Mallat Z
    Curr Opin Pharmacol; 2010 Apr; 10(2):197-202. PubMed ID: 20207195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.